Results 1 -
10
of
17
for
"Pheochromocytoma," susceptibility to
- ... RC, Dahia PL. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet. 2010 Mar;42(3):229-33. ...
- ... RC, Dahia PL. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet. 2010 Mar;42(3):229-33. ...
- ... mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet. ...
- ... mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet. ...
- Stages of Pheochromocytoma and Paraganglioma (National Cancer Institute)Pheochromocytoma and paraganglioma treatment is usually surgery and drug therapy. Chemotherapy, radiation therapy, targeted therapy, ablation, and embolization ...
- General Information about Pheochromocytoma and Paraganglioma (National Cancer Institute)Pheochromocytoma/Start Here ... Pheochromocytoma ... Pheochromocytoma and paraganglioma treatment is usually surgery and drug therapy. Chemotherapy, radiation therapy, ...
- Treatment Option Overview (Pheochromocytoma and Paraganglioma) (National Cancer Institute)Pheochromocytoma/Treatments and Therapies ... Pheochromocytoma ... National Cancer Institute ... From the National Institutes of Health ... Pheochromocytoma and paraganglioma ...
- Pheochromocytoma during Pregnancy (National Cancer Institute)Tumors and Pregnancy/Specifics ... Tumors and Pregnancy ... National Cancer Institute ... From the National Institutes of Health ... Pheochromocytoma and paraganglioma treatment ...
- Childhood Multiple Endocrine Neoplasia (MEN) Syndromes Treatment (National Cancer Institute)Endocrine Diseases/Children ... Endocrine Diseases ... Cancer/Children ... Cancer ... National Cancer Institute ... From the National Institutes of Health ... Expert-reviewed information ...
- Rare Cancers of Childhood Treatment (National Cancer Institute)Treatment for rare cancers of childhood depends on the specific cancer (e.g., nasopharyngeal, thyroid, oral, laryngeal, lung, esophageal, cardiac). See ...